B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin

Hemophilia A is an inherited coagulation disorder resulting in the loss of functional clotting factor VIII (FVIII). Presently, the most effective treatment is prophylactic protein replacement therapy. However, this requires frequent life-long intravenous infusions of plasma derived or recombinant cl...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Moanaro Biswas, Brett Palaschak, Sandeep R. P. Kumar, Jyoti Rana, David M. Markusic
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2020-06-01
Ráidu:	Frontiers in Immunology
Fáttát:	hemophilia A inhibitors gene therapy AAV anti-CD20 rapamycin
Liŋkkat:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01293/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!